慢性乙型肝炎患者二维剪切波肝脏弹性成像定量和外周血ALP/PLT比值的变化研究*

doi:10.3969/j.issn.1672-5069.2024.01.007

摘要/Abstract

摘要： 目的探讨慢性乙型肝炎(CHB)患者二维剪切波弹性成像(SWE)定量和外周血碱性磷酸酶(ALP)/血小板(PLT)比值变化及其与肝纤维化程度的关系。方法 2019年5月～2022年5月内蒙古自治区人民医院诊治的CHB患者120例,均接受肝活检病理学检查,使用超声检测肝脏杨氏模量值,常规检测血清ALP水平和全血PLT计数。采用Spearman相关性分析法分析ALP/PLT比值和杨氏模量值与肝纤维化程度的相关性。结果在120例CHB患者中,经肝组织病理学检查,发现F0/F1期38例(31.7%),F2期32例(26.7%),F3期32例(26.7%)和F4期18例(15.0%);F4期CHB患者血清ALP、外周血PLT计数、ALP/PLT比值和杨氏模量值分别为(197.1±39.7)U/L、(114.2±35.1)×10⁹/L、(1.7±0.3)和(11.7±1.7)kPa,显著不同于F3期【分别为(180.9±43.8)U/L、(137.1±38.6)×10⁹/L、(1.3±0.4)和(8.6±1.5)kPa,P均＜0.05】或F2期【分别为(162.7±41.1)U/L、(154.6±39.8)×10⁹/L、(0.9±0.2)和(6.4±1.0)kPa,P均＜0.05】或F0/F1期【分别为(150.5±36.4)U/L、(181.7±37.2)×10⁹/L、(0.7±0.2)和(5.3±1.1)kPa,P均＜0.05】;经Spearman相关性分析显示,杨氏模量值和ALP/PLT比值与肝纤维化分期均呈显著性正相关(r=0.79,P＜0.05;r=0.75,P＜0.05)。结论 CHB患者肝脏超声杨氏模量值和ALP/PLT比值水平均与肝纤维化分期呈显著性正相关,或对诊断肝纤维化分期有帮助,值得进一步研究。

关键词: 慢性乙型肝炎, 肝纤维化, 剪切波弹性成像, 杨氏模量值, 碱性磷酸酶/血小板计数比值

Abstract: Objective The aim of this study was to explore the correlation of liver Young's modulus by two-dimensional shear wave elastography (SWE) and alkaline phosphatase (ALP)/platelet (PLT) ratio to liver fibrosis in patients with chronic hepatitis B (CHB). Methods 120 patients with CHB were admitted to the Provincial People's Hospital, Inner Mongolia Autonomous Region between May 2019 and May 2022, and all patients underwent liver biopsy. The liver Young's modulus was obtained by ultrasonography, and serum ALP and whole blood PLT counts were detected routinely. The correlation of ALP / PLT ratio and Young's modulus to liver fibrosis was determined by Spearman correlation analysis. Results Out of the 120 patients with CHB, the liver histopathological examination showed F0/F1 stage in 38 cases(31.7%), F2 stage in 32 cases(26.7%), F3 stage in 32 cases(26.7%) and F4 stage in 18 cases (15.0%); serum ALP, blood PLT counts, ALP/PLT ratio and Young's modulus in patients with F4 were (197.1±39.7)U/L, (114.2±35.1)×10⁹/L, (1.7±0.3) and (11.7±1.7)kPa, all significantly different compared to [(180.9±43.8)U/L, (137.1±38.6)×10⁹/L, (1.3±0.4) and (8.6±1.5) kPa, respectively, all P＜0.05] in patients with F3 or [(162.7±41.1)U/L,(154.6±39.8)×10⁹/L,(0.9±0.2) and (6.4±1.0)kPa, respectively, all P＜0.05] in patients with F2 or [(150.5±36.4)U/L, (181.7±37.2)×10⁹/L, (0.7±0.2) and (5.3±1.1)kPa, respectively, all P＜0.05] in patients with F0/F1; the Spearman analysis showed that the Young's modulus and ALP/PLT ration in patients with CHB were positively correlated to liver fibrosis staging (r=0.79, P＜0.05; r=0.75, P＜0.05). Conclusion The Young's modulus and ALP / PLT ratio in patients with CHB are correlated to liver fibrosis, which might help predict the liver fibrosis staging and warrants further clinical investigation.

Key words: Hepatitis B, Liver fibrosis, Shear wave elastography, Young's modulus, Alkaline phosphatase to platelet ratio

武雯雯, 仇艳坤. 慢性乙型肝炎患者二维剪切波肝脏弹性成像定量和外周血ALP/PLT比值的变化研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 24-27.

Wu Wenwen, Qiu Yankun. Correlation of liver Young's modulus by two-dimensional shear wave elastography and ALP/PLT ratio to liver fibrosis in patients with chronic hepatitis B[J]. Journal of Practical Hepatology, 2024, 27(1): 24-27.

参考文献

[1] Khomich O, Ivanov A V, Bartosch B. Metabolic hallmarks of hepatic stellate sells in liver fibrosis. Cells,2019,9(1):24-29.
[2] Pantano L, Agyapong G, Shen Y, et al. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Sci Rep,2021,11(1):18045.
[3] Gheorghe G, Bungau S, Ceobanu G, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc,2021,120(2):794-803.
[4] 德吉,白玛,白央,等. CHB和肝硬化患者肝脏硬度检测值的变化及其影响因素分析. 实用肝脏病杂志,2019,22(3):401-404.
[5] 李曼,张军,李涛,等. ADA/PLT、ALP/PLT比值比值对肝纤维化的诊断价值. 中国实验诊断学,2017,21(11):1923-1926.
[6] 中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版). 中华肝脏病杂志,2019,27(7):494-504.
[7] 江超,郭鲁,时丹丹,等. 二维剪切波弹性成像检测乳腺癌术后化疗患者肝弹性值变化的应用价值. 中华超声影像学杂志,2022,31(4):312-317.
[8] Borro P, Ziola S, Pasta A, et al. Hepatic elastometry and glissonian Line in the assessment of liver fibrosis. Ultrasound Med Biol,2021,47(4):947-959.
[9] Fuentes-Velez S, Fagoonee S, Sanginario A, et al. Electrical impedance-based characterization of hepatic tissue with early-stage fibrosis. Biosensors (Basel),2022,12(2):116-119.
[10] Jin K, Wang H, Zeng M, et al. A comparative study of MR extracellular volume fraction measurement and two-dimensional shear-wave elastography in assessment of liver fibrosis with chronic hepatitis B. Abdom Radiol (NY),2019,44(4):1407-1414.
[11] Chin J, Powell L W, Ramm L E, et al. Utility of serum biomarker indices for staging of hepatic fibrosis before and after venesection in patients with hemochromatosis caused by variants in HFE. Clin Gastroenterol Hepatol,2021,19(7):1459-1468.
[12] Albillos A, Martin-Mateos R, Van der Merwe S, et al. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol,2022,19(2):112-134.
[13] Kim M N, Lee J H, Chon Y E, et al. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. Eur J Gastroenterol Hepatol,2020,32(3):433-439.
[14] Dong B, Lyu G, Chen Y, et al. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis b: a meta-analysis. Expert Rev Gastroenterol Hepatol,2021,15(9):1077-1089.
[15] Baldea V, Sporea I, Tudor A, et al. Virtual touch quantification using acoustic radiation force impulse imaging technology versus transient elastography for the noninvasive assessment of liver fibrosis in patients with chronic hepatitis B or C using liver biopsy as the gold standard. J Gastrointestin Liver Dis,2020,29(2):181-190.
[16] 杨艳秋,程颢,冯敏. 肝脏剪切波弹性成像对CHB患者肝纤维化的评估价值. 实用肝脏病杂志,2021,24(4):480-483.
[17] Nabavizadeh A, Payen T, Iuga AC, et al. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using harmonic motion elastography (HME) in vivo. Theranostics,2020,10(10):4616-4626.
[18] Gatselis NK, Goet JC, Zachou K, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis. Clin Gastroenterol Hepatol,2020,18(3):684-692.
[19] Gold L C, Macpherson I, Nobes J H, et al. Thrombocytosis and abnormal liver enzymes: a trigger for investigation of underlying malignancy. PLoS One,2022,17(4):267-274.
[20] Dong B, Huang S, Chang J, et al. Comparison of sound touch elastography, sound touch quantify, and 4 serum fibrosis indexes for the diagnosis of liver fibrosis in patients with chronic hepatitis B. Ultrasound Q,2021,37(2):123-128.
[21] Cheng M Q, Hu H T, Huang H, et al. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade. Eur Radiol,2021,31(8):5680-5688.
[22] 翟相威,刘树红,姚明解,等. 基于血清高尔基体蛋白73的代偿期乙型肝炎肝硬化无创诊断模型的建立及初步应用. 中华肝脏病杂志,2020,28(1):47-52.
[23] Nielsen MJ, Leeming DJ, Goodman Z, et al. Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. J Hepatol,2021,75(6):1292-1300.
[24] Pan Y, Yang K, Sun B, et al. Application of alkaline phosphatasetoplatelet ratio as a novel noninvasive index predicts liver fibrosis in patients with chronic hepatitis B. Exp Ther Med,2022,24(4):619-692.
[25] Pyo JY, Ahn SS, Lee LE, et al. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases. Clinics (Sao Paulo),2021,76(1):2501.

慢性乙型肝炎患者二维剪切波肝脏弹性成像定量和外周血ALP/PLT比值的变化研究^*

Correlation of liver Young's modulus by two-dimensional shear wave elastography and ALP/PLT ratio to liver fibrosis in patients with chronic hepatitis B

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李凯, 石波, 程序, 赵凯. 应用STE/STQ技术评估慢性乙型肝炎患者肝纤维化程度效能研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 20-23.
[2]	张书琴, 王婷婷, 张艳红. 实时组织弹性成像评估非酒精性脂肪性肝炎患者肝纤维化分期临床价值研究^*[J]. 实用肝脏病杂志, 2024, 27(1): 48-51.
[3]	宋涛, 徐敏, 党子龙, 孙珺珺. 恩替卡韦联合α-干扰素治疗慢性乙型肝炎患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 785-788.
[4]	高丽娟, 李永库, 董新颖, 杨艺宁, 冷雪君. 艾米替诺福韦治疗慢性乙型肝炎患者疗效初步研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 789-792.
[5]	周季颖, 谢月红, 于翠霞. 恩替卡韦治疗慢性乙型肝炎合并非酒精性脂肪性肝病患者疗效研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 793-796.
[6]	阎道博, 朱海超, 闪海霞. 瞬时弹性成像联合APRI诊断自身免疫性肝炎患者肝纤维化效能研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 831-834.
[7]	邹涛, 张敏, 杨凡, 王丽, 喻峰. 慢性乙型肝炎和乙型肝炎肝硬化患者PBMCs 信号转导和转录激活因子3及血清可溶性CD30分子水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 855-858.
[8]	贺梅年, 赵思佳, 田智超, 何秀英, 巴正武. 超声半定量评分结合弹性成像诊断慢性乙型肝炎患者早期肝硬化临床价值分析^*[J]. 实用肝脏病杂志, 2023, 26(6): 871-874.
[9]	盛秋菊, 窦晓光. 慢性HBV感染不同疾病状态治疗策略选择与获益评价[J]. 实用肝脏病杂志, 2023, 26(5): 609-611.
[10]	张丹, 丁洋. 慢性乙型肝炎患者病毒载量与疾病状态和治疗策略选择^*[J]. 实用肝脏病杂志, 2023, 26(5): 612-614.
[11]	黄柏盛, 区蓝芯, 张莹洁, 方梦冰, 施梅姐, 黎胜, 萧焕明. FibroScan联合GPR、APRI和FIB-4诊断血清ALT正常的慢性HBV感染者肝纤维化价值分析^*[J]. 实用肝脏病杂志, 2023, 26(5): 618-621.
[12]	吴育龙, 庄见齐, 刘志成, 马侠槟. 核苷(酸)类似物治疗慢性乙型肝炎患者血清HBV pgRNA变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(5): 622-625.
[13]	王一卓, 张崴琪, 李红. 聚乙二醇干扰素α-2a治疗HBeAg阳性慢性乙型肝炎患者3年随访研究[J]. 实用肝脏病杂志, 2023, 26(5): 626-629.
[14]	郝岸华, 杜忠彩, 周林, 马磊. 慢性乙型肝炎患者肝脏硬度检测和S指数变化及评估肝纤维化程度应用价值探讨^*[J]. 实用肝脏病杂志, 2023, 26(5): 630-633.
[15]	刘爱华, 符建, 陈小红. 瞬时超声弹性成像联合GGT/PLT比值预测慢性乙型肝炎患者肝纤维化价值研究^*[J]. 实用肝脏病杂志, 2023, 26(5): 634-637.